India's Venus Remedies surges as quarterly profit doubles
** Shares of Venus Remedies VENR.NS rise as much as 17.21% to 426 rupees, highest since Aug 2024 ** Stock last up 11.6%; trading volume at ~15x the 30-day avg, with stock set for most active session since Feb 6 ** Pharma firm's March-qtr net profit doubles to 210 mln rupees ($2.5 mln); rev little changed; total costs fall 6% ** Stock now up ~14 YTD ($1 = 85.3500 Indian rupees) (Reporting by Bharath Rajeswaran in Bengaluru) ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))
Recent news on Venus Remedies
See all newsBrief: Venus Remedies Sept-Quarter Consol Net Profit 256.5 Million Rupees
Brief: Venus Remedies Secured Five Marketing Authorisations Across Kazakhstan, Peru, Kuwait And Argentina
India's Venus Remedies rises after quarterly profit more than doubles
Brief: Venus Remedies June-Quarter Consol Net Profit 229.7 Million Rupees
India raises price cap on cancer drugs to tackle shortage